Bioxytran (BIXT) Accounts Payables (2010 - 2026)
Bioxytran's Accounts Payables was $1.2 million in Q2 2026, up 63.2% from $734,618 a year earlier and up 12.5% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Bioxytran came in at $824,278, up 196.2% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $278,258 in FY2024 (-8.1%), $302,681 in FY2023 (-59.8%), $753,824 in FY2022 (+20.7%) and $624,316 in FY2021 (+79.3%).
- The Q2 2026 figure marks the highest quarterly Accounts Payables in data going back to Q4 2010.
- Compared with a year earlier, Accounts Payables has increased for three straight quarters, with growth averaging 110.2% over the last eight quarters.
- The best year-over-year quarter for Accounts Payables over five years was Q1 2025 (growth of 469.5%); the worst was Q3 2025 (a decline of 98.3%).
- Per Business Quant data, BIXT's Accounts Payables in the three quarters before Q2 2026 was $1.07 million (Q1 2026), $824,278 (Q4 2025) and $1,653 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 824,278.00 |
| Sep 30, 2025 | 1,653.00 |
| Jun 30, 2025 | 734,618.00 |
| Mar 31, 2025 | 555,792.00 |
| Dec 31, 2024 | 278,258.00 |
| Sep 30, 2024 | 98,426.00 |
| Jun 30, 2024 | 216,526.00 |
| Mar 31, 2024 | 97,591.00 |
| Dec 31, 2023 | 302,681.00 |
| Sep 30, 2023 | 352,572.00 |
| Jun 30, 2023 | 562,662.00 |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 753,824.00 |
| Sep 30, 2022 | 341,511.00 |
| Jun 30, 2022 | 556,835.00 |
| Mar 31, 2022 | 516,139.00 |
| Dec 31, 2021 | 624,316.00 |
| Sep 30, 2021 | 248,218.00 |
API Access
Bioxytran Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();